Moneycontrol PRO

you are here: HomeNewsBusinessCompaniesAnalysts doubt veracity of US API import ban report

SHOW NAMES

Trending Topics

Sensex Live Urban Company IPO GMP Shringar House of Mangalsutra IPO GMP Gold Silver ETFs IT Stocks

business

Analysts doubt veracity of US API import ban report

A report today said the US government has made it mandatory for all active pharmaceutical ingredients (APIs) to be manufactured locally. But analysts said it was unlikely such a law could have been passed.

first published: Feb 4, 2016 11:56 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347